Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) CEO Christopher U. Missling sold 73,380 shares of the business’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $5.11, for a total transaction of $374,971.80. Following the transaction, the chief executive officer now owns 1,250,210 shares in […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report)’s stock price rose 6% on Monday . The company traded as high as $6.72 and last traded at $6.71. Approximately 515,967 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 1,793,583 shares. The stock had previously closed at $6.33. […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) shares rose 7.6% during mid-day trading on Monday . The company traded as high as $6.58 and last traded at $6.51. Approximately 780,693 shares changed hands during trading, a decline of 63% from the average daily volume of 2,115,367 shares. The stock had previously closed at […]
Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 20,070,000 shares, an increase of 10.8% from the December 15th total of 18,120,000 shares. Based on an average daily trading volume, of […]
Anavex Life Sciences (NASDAQ:AVXL – Free Report) had its price target decreased by HC Wainwright from $54.00 to $40.00 in a research report released on Wednesday, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Anavex Life Sciences’ Q1 2024 earnings at ($0.15) EPS, […]